Pulmonary hypertension of the newborn

Best Practice and Research: Clinical Anaesthesiology

Volumn 24, Issue 3, 2010, Pages 375-386

  Stayer, Stephen A ^a   Liu, Yang ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Congenital diaphragmatic hernia inhaled nitric oxide; Extra corporeal membrane oxygenation; Neonatal pulmonary hypertension; Persistent pulmonary hypertension of the newborn

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; MILRINONE; NITRIC OXIDE; SILDENAFIL; VASODILATOR AGENT; ANESTHETIC AGENT;

ACIDOSIS; ARTERIOVENOUS MALFORMATION; ARTICLE; ARTIFICIAL VENTILATION; CONGENITAL DIAPHRAGM HERNIA; CONGENITAL HEART MALFORMATION; EXTRACORPOREAL OXYGENATION; FETUS CIRCULATION; HEART RIGHT LEFT SHUNT; HIGH OUTPUT HEART FAILURE; HUMAN; HYPERTENSIVE CRISIS; HYPOXEMIA; INCIDENCE; LUNG BLOOD FLOW; LUNG HYPOPLASIA; LUNG VASCULAR RESISTANCE; LUNG VEIN DRAINAGE ANOMALY; MECONIUM ASPIRATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN DISEASE; NEWBORN MORBIDITY; NEWBORN MORTALITY; PATHOPHYSIOLOGY; PERINATAL ASPHYXIA; PERSISTENT PULMONARY HYPERTENSION; PRIORITY JOURNAL; PULMONARY ARTERY MALFORMATION; PULMONARY VASCULAR DISEASE; ANESTHESIA; DIAPHRAGM HERNIA; DRUG EFFECT; METHODOLOGY; NEWBORN; REVIEW; VASCULAR RESISTANCE;

ANESTHESIA; ANESTHETICS; HEART DEFECTS, CONGENITAL; HERNIA, DIAPHRAGMATIC; HUMANS; INFANT, NEWBORN; PERSISTENT FETAL CIRCULATION SYNDROME; VASCULAR RESISTANCE;

EID: 79952108913     PISSN: 15216896     EISSN: 1532169X     Source Type: Journal    
DOI: 10.1016/j.bpa.2010.02.021     Document Type: Article

References (73)

1. Walsh-Sukys MC, Tyson JE, Wright LL et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000 Jan; 105(1 Pt 1): 14-20. (Pubitemid 30035712)
2. Konduri GG, Solimano A, Sokol GM et al. A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure. Pediatrics 2004 Mar; 113(3 Pt 1): 559-564. (Pubitemid 38280798)
3. Ziegler JW, Ivy DD, Kinsella JP & Abman SH. The role of nitric oxide, endothelin, and prostaglandins in the transition of the pulmonary circulation. Clinics in Perinatology 1995 Jun; 22(2): 387-403.
4. Steinhorn RH, Millard SL & Morin III FC. Persistent pulmonary hypertension of the newborn. Role of nitric oxide and endothelin in pathophysiology and treatment. Clinics in Perinatology 1995 Jun; 22(2): 405-428.
5. Berger S & Konduri GG. Pulmonary hypertension in children: the twenty-first century. Pediatric Clinics of North America 2006 Oct; 53(5): 961-987. x. (Pubitemid 44488699)
6. Marshall C & Marshall B. Site and sensitivity for stimulation of hypoxic pulmonary vasoconstriction. Journal of Applied Physiology 1983 Sep; 55(3): 711-716. (Pubitemid 13005752)
7. Benumof JL, Mathers JM & Wahrenbrock EA. Cyclic hypoxic pulmonary vasoconstriction induced by concomitant carbon dioxide changes. Journal of Applied Physiology 1976 Oct; 41(4): 466-469.
8. Levin DL. Morphologic analysis of the pulmonary vascular bed in congenital left-sided diaphragmatic hernia. The Journal of Pediatrics 1978 May; 92(5): 805-809. (Pubitemid 8314617)
9. Geggel RL, Murphy JD, Langleben D et al. Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair. The Journal of Pediatrics 1985 Sep; 107(3): 457-464. (Pubitemid 15240809)
10. Murphy JD, Rabinovitch M, Goldstein JD & Reid LM. The structural basis of persistent pulmonary hypertension of the newborn infant. The Journal of Pediatrics 1981 Jun; 98(6): 962-967. (Pubitemid 11093063)
11. Christou H, Adatia I, Van Marter LJ et al. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. The Journal of Pediatrics 1997 Apr; 130(4): 603-611. (Pubitemid 27492652)
12. Chambers CD, Hernandez-Diaz S, Van Marter LJ et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. The New England Journal of Medicine 2006 Feb 9; 354(6): 579-587. (Pubitemid 43209105)
13. Eddahibi S, Raffestin B, Hamon M & Adnot S. Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension? The Journal of Laboratory and Clinical Medicine 2002 Apr; 139(4): 194-201. (Pubitemid 34557354)
14. Curtis J, Kim G, Wehr NB & Levine RL. Group B streptococcal phospholipid causes pulmonary hypertension. Proceedings of the National Academy of Sciences of the United States of America 2003 Apr 29; 100(9): 5087-5090. (Pubitemid 36542662)
15. Ashida Y, Miyahara H, Sawada H et al. Anesthetic management of a neonate with vein of Galen aneurysmal malformations and severe pulmonary hypertension. Paediatric Anaesthesia 2005 Jun; 15(6): 525-528. (Pubitemid 40813881)
16. Hendson L, Emery DJ, Phillipos EZ et al. Persistent pulmonary hypertension of the newborn presenting as the primary manifestation of intracranial arteriovenous malformation of the Vein of Galen. American Journal of Perinatology 2000; 17(8): 405-410. (Pubitemid 32039332)
17. Dahdah NS, Alesseh H, Dahms B & Saker F. Severe pulmonary hypertensive vascular disease in two newborns with aneurysmal vein of Galen. Pediatric Cardiology 2001 Nov; 22(6): 538-541. (Pubitemid 33131594)
18. Rodesch G, Hui F, Alvarez H et al. Prognosis of antenatally diagnosed vein of Galen aneurysmal malformations. Child's Nervous System 1994 Mar; 10(2): 79-83. (Pubitemid 24131049)
19. Granton JT & Rabinovitch M. Pulmonary arterial hypertension in congenital heart disease. Cardiology Clinics 2002 Aug; 20 (3): 441-457. vii.
20. Steele PM, Fuster V, Cohen M et al. Isolated atrial septal defect with pulmonary vascular obstructive disease-long-term follow-up and prediction of outcome after surgical correction. Circulation 1987 Nov; 76(5): 1037-1042. (Pubitemid 17157284)
21. Lindberg L, Olsson AK, Jogi P & Jonmarker C. How common is severe pulmonary hypertension after pediatric cardiac surgery? The Journal of Thoracic and Cardiovascular Surgery 2002 Jun; 123(6): 1155-1163.
22. Carmosino MJ, Friesen RH, Doran A & Ivy DD. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesthesia and Analgesia 2007 Mar; 104(3): 521-527.
23. Rudolph AM & Yuan S. Response of the pulmonary vasculature to hypoxia and H+ ion concentration changes. The Journal of Clinical Investigation 1966 Mar; 45(3): 399-411.
24. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. The Neonatal Inhaled Nitric Oxide Study Group. The New England Journal of Medicine 1997 Feb 27; 336(9): 597-604.
25. Bossone E, Bodini BD, Mazza A & Allegra L. Pulmonary arterial hypertension: the key role of echocardiography. Chest 2005 May; 127(5): 1836-1843. (Pubitemid 46218815)
26. Denton CP, Cailes JB, Phillips GD et al. Comparison of doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. British Journal of Rheumatology 1997 Feb; 36(2): 239-243.
27. Kinsella JP, Truog WE, Walsh WF et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. The Journal of Pediatrics 1997 Jul; 131(1 Pt 1): 55-62. (Pubitemid 27498309)
28. Seri I. Circulatory support of the sick preterm infant. Seminars in Neonatology 2001 Feb; 6(1): 85-95. (Pubitemid 32127006)
29. Lotze A, Mitchell BR, Bulas DI et al. Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in term infants study group. The Journal of Pediatrics 1998 Jan; 132(1): 40-47. (Pubitemid 28082529)
30. Tworetzky W, Bristow J, Moore P et al. Inhaled nitric oxide in neonates with persistent pulmonary hypertension. Lancet 2001 Jan 13; 357(9250): 118-120. (Pubitemid 32094918)
31. Davidson D, Barefield ES, Kattwinkel J et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The INO/ PPHN Study Group. Pediatrics 1998 Mar; 101(3 Pt 1): 325-334. (Pubitemid 28136402)
32. Finer NN & Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database of Systematic Reviews (Online) 2006; 4. CD000399.
33. Konduri GG & Kim UO. Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatric Clinics of North America 2009 Jun; 56(3): 579-600, table.
34. Schulze-Neick I, Hartenstein P, Li J et al. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 2003 Sep 9; 108(Suppl. 1): II167-II173. (Pubitemid 37099949)
35. Atz AM, Lefler AK, Fairbrother DL et al. Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. The Journal of Thoracic and Cardiovascular Surgery 2002 Sep; 124(3): 628-629.
36. Baquero H, Soliz A, Neira F et al. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 2006 Apr; 117(4): 1077-1083. (Pubitemid 46071498)
37. Bahrami KR & Van Meurs KP. ECMO for neonatal respiratory failure. Seminars in Perinatology 2005 Feb; 29(1): 15-23. (Pubitemid 40488987)
38. Takayasu H, Nakazawa N, Montedonico S et al. Impaired alveolar epithelial cell differentiation in the hypoplastic lung in nitrofen-induced congenital diaphragmatic hernia. Pediatric Surgery International 2007 May; 23(5): 405-410. (Pubitemid 46626226)
39. Davey M. Surfactant levels in congenital diaphragmatic hernia. PLoS Medicine 2007 Jul 31; 4(7): e243.
40. Logan JW, Cotten CM, Goldberg RN & Clark RH. Mechanical ventilation strategies in the management of congenital diaphragmatic hernia. Seminars in Pediatric Surgery 2007 May; 16(2): 115-125. (Pubitemid 46617308)
41. Wung JT, Sahni R, Moffitt ST et al. Congenital diaphragmatic hernia: survival treated with very delayed surgery, spontaneous respiration, and no chest tube. Journal of Pediatric Surgery 1995 Mar; 30(3): 406-409.
42. Saugstad OD. Oxygen toxicity in the neonatal period. Acta Paediatrica Scandinavica 1990 Oct; 79(10): 881-892. (Pubitemid 20333494)
43. Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The neonatal inhaled nitric oxide study group (NINOS). Pediatrics 1997 Jun; 99(6): 838-845.
44. Morray JP, Geiduschek JM, Ramamoorthy C et al. Anesthesia-related cardiac arrest in children: initial findings of the Pediatric Perioperative cardiac arrest (POCA) registry. Anesthesiology 2000 Jul; 93(1): 6-14. (Pubitemid 30436671)
45. Bennett D, Marcus R & Stokes M. Incidents and complications during pediatric cardiac catheterization. Paediatric Anaesthesia 2005 Dec; 15(12): 1083-1088. (Pubitemid 43965386)
46. Blaise G, Langleben D & Hubert B. Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology 2003 Dec; 99(6): 1415-1432. (Pubitemid 37475190)
47. Fischer LG, Van AH & Burkle H. Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesthesia and Analgesia 2003 Jun; 96(6): 1603-1616. (Pubitemid 36623112)
48. Lennon PF & Murray PA. Isoflurane and the pulmonary vascular pressure-flow relation at baseline and during sympathetic alpha - and beta-adrenoreceptor activation in chronically instrumented dogs. Anesthesiology 1995 Mar; 82(3): 723-733.
49. Gambone LM, Murray PA & Flavahan NA. Isoflurane anesthesia attenuates endothelium-dependent pulmonary vasorelaxation by inhibiting the synergistic interaction between nitric oxide and prostacyclin. Anesthesiology 1997 Apr; 86(4): 936-944.
50. Nakayama M, Kondo U & Murray PA. Pulmonary vasodilator response to adenosine triphosphate-sensitive potassium channel activation is attenuated during desflurane but preserved during sevoflurane anesthesia compared with the conscious state. Anesthesiology 1998 Apr; 88(4): 1023-1035. (Pubitemid 28193330)
51. Mikhail GW, Gibbs JS & Yacoub MH. Pulmonary and systemic arterial pressure changes during syncope in primary pulmonary hypertension. Circulation 2001 Sep 11; 104(11): 1326-1327. (Pubitemid 32848125)
52. Sykes MK, Hurtig JB, Tait AR & Chakrabarti MK. Reduction of hypoxic pulmonary vasoconstriction in the dog during administration of nitrous oxide. British Journal of Anaesthesia 1977 Apr; 49(4): 301-307. (Pubitemid 8066193)
53. Benumof JL & Wahrenbrock EA. Local effects of anesthetics on regional hypoxic pulmonary vasoconstriction. Anesthesiology 1975 Nov; 43(5): 525-532.
54. Heerdt PM & Caldwell RW. The mechanism of nitrous oxide-induced changes in pulmonary vascular resistance in a dog model of left atrial outflow obstruction. Journal of Cardiothoracic Anesthesia 1989 Oct; 3(5): 568-573. (Pubitemid 19265902)
55. Schulte-Sasse U, Hess W & Tarnow J. Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology 1982 Jul; 57(1): 9-13. (Pubitemid 12087547)
56. Hickey PR, Hansen DD, Strafford M et al. Pulmonary and systemic hemodynamic effects of nitrous oxide in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 1986 Oct; 65(4): 374-378. (Pubitemid 16031799)
57. Mulier JP, Wouters PF, Van AH et al. Cardiodynamic effects of propofol in comparison with thiopental: assessment with a transesophageal echocardiographic approach. Anesthesia and Analgesia 1991 Jan; 72(1): 28-35.
58. Williams GD, Jones TK, Hanson KA & Morray JP. The hemodynamic effects of propofol in children with congenital heart disease. Anesthesia and Analgesia 1999 Dec; 89(6): 1411-1416.
59. Morray JP, Lynn AM, Stamm SJ et al. Hemodynamic effects of ketamine in children with congenital heart disease. Anesthesia and Analgesia 1984 Oct; 63(10): 895-899. (Pubitemid 14048655)
60. Wolfe RR, Loehr JP, Schaffer MS & Wiggins Jr. JW. Hemodynamic effects of ketamine, hypoxia and hyperoxia in children with surgically treated congenital heart disease residing greater than or equal to 1,200 meters above sea level. The American Journal of Cardiology 1991 Jan 1; 67(1): 84-87.
61. Hickey PR, Hansen DD, Cramolini GM et al. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 1985 Mar; 62(3): 287-293. (Pubitemid 15101878)
62. White PF,Way WL & Trevor AJ. Ketamine-its pharmacology and therapeutic uses. Anesthesiology 1982 Feb; 56(2): 119-136.
63. Hickey PR, Hansen DD, Wessel DL et al. Blunting of stress responses in the pulmonary circulation of infants by fentanyl. Anesthesia and Analgesia 1985 Dec; 64(12): 1137-1142. (Pubitemid 16258108)
64. Rivenes SM, Lewin MB, Stayer SA et al. Cardiovascular effects of sevoflurane, isoflurane, halothane, and fentanyl-midazolam in children with congenital heart disease: an echocardiographic study of myocardial contractility and hemodynamics. Anesthesiology 2001 Feb; 94(2): 223-229. (Pubitemid 32125910)
65. Laird TH, Stayer SA, Rivenes SM et al. Pulmonary-to-systemic blood flow ratio effects of sevoflurane, isoflurane, halothane, and fentanyl/midazolam with 100% oxygen in children with congenital heart disease. Anesthesia and Analgesia 2002 Nov; 95(5): 1200-1206, table. (Pubitemid 35239108)
66. Reves JG, Kissin I, Lell WA & Tosone S. Calcium entry blockers: uses and implications for anesthesiologists. Anesthesiology 1982 Dec; 57(6): 504-518. (Pubitemid 13247512)
67. Gaine S. Pulmonary hypertension. JAMA 2000 Dec 27; 284(24): 3160-3168. (Pubitemid 32039080)
68. Tanaka H, Tajimi K, Moritsune O et al. Effects of milrinone on pulmonary vasculature in normal dogs and in dogs with pulmonary hypertension. Critical Care Medicine 1991 Jan; 19(1): 68-74.
69. Burrows FA, Klinck JR, Rabinovitch M & Bohn DJ. Pulmonary hypertension in children: perioperative management. Canadian Anaesthetists' Society Journal 1986 Sep; 33(5): 606-628. (Pubitemid 16022438)
70. Wessel DL. Hemodynamic responses to perioperative pain and stress in infants. Critical Care Medicine 1993 Sep; 21(9 Suppl): S361-S362. (Pubitemid 23270554)
71. Atz AM, Adatia I & Wessel DL. Rebound pulmonary hypertension after inhalation of nitric oxide. The Annals of Thoracic Surgery 1996 Dec; 62(6): 1759-1764. (Pubitemid 26421112)
72. Ivy DD, Griebel JL, Kinsella JP & Abman SH. Acute hemodynamic effects of pulsed delivery of low flow nasal nitric oxide in children with pulmonary hypertension. The Journal of Pediatrics 1998 Sep; 133(3): 453-456. (Pubitemid 28413635)
73. Ivy DD, Kinsella JP, Ziegler JW & Abman SH. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. The Journal of Thoracic and Cardiovascular Surgery 1998 Apr; 115 (4): 875-882. (Pubitemid 28196599)